| Detected | Trial | Change |
|---|---|---|
| 2026-05-23 | NCT04302025 A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages… |
Primary endpoint(s) modified |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT03768063 | A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd… | Cancer | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT03178552 | A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments… | Non-Small Cell Lung Cancer | Active, Not Recruiting |
| Phase 2 | |||
| NCT06440850 | Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated… | Thyroid Gland Follicular Carcinoma | Recruiting |
| NCT04943198 | Optimization of the Time and Dosage of Vemurafenib in BRAF Positive Juvenile Patients… | Histiocytosis | Recruiting |
| NCT06561360 | A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People… | Hairy Cell Leukemia | Recruiting |
| NCT04302025 | A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages… | Non-small Cell Lung Cancer | Recruiting |
| NCT03181100 | Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly… | Metastatic Thyroid Gland Carcinoma | Active, Not Recruiting |
| NCT03410875 | A Phase II Study of the BRAF Inhibitor, Vemurafenib, Plus Obinutuzumab in Patients With… | Hairy Cell Leukemia | Active, Not Recruiting |
| NCT01709292 | Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer | Thyroid Cancer | Active, Not Recruiting |
| NCT03155620 | Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed… | Advanced Malignant Solid Neoplasm | Active, Not Recruiting |
| NCT03224767 | Vemurafenib and Cobimetinib in Treating Patients With BRAF V600E Mutation Positive… | BRAF V600E Mutation Present | Active, Not Recruiting |
| Phase 1 | |||
| NCT02721459 | XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma | Melanoma | Active, Not Recruiting |